|
|
|
Volumn 67, Issue 3, 2000, Pages 143-145
|
|
Bone loss prevention and breast cancer risk
|
|
Author keywords
Breast cancer; Osteoporosis; Postmenopausal hormone replacement therapy
|
|
Indexed keywords
ALENDRONIC ACID;
BISPHOSPHONIC ACID DERIVATIVE;
ESTRADIOL;
ESTROGEN;
ESTROGEN RECEPTOR;
PROGESTERONE;
RALOXIFENE;
RISEDRONIC ACID;
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
ADULT;
BODY MASS;
BONE ATROPHY;
BREAST CANCER;
CANCER RISK;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
DEEP VEIN THROMBOSIS;
EDITORIAL;
ESTROGEN THERAPY;
FEMALE;
HORMONE SUBSTITUTION;
HOT FLUSH;
HUMAN;
MAJOR CLINICAL STUDY;
META ANALYSIS;
OSTEOPOROSIS;
POSTMENOPAUSE OSTEOPOROSIS;
RISK ASSESSMENT;
BREAST NEOPLASMS;
ESTROGEN REPLACEMENT THERAPY;
FEMALE;
HUMANS;
OSTEOPOROSIS;
RISK FACTORS;
|
|
EID: 0034078306
PISSN: 11698446
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
|
Times cited : (3)
|
|
References (13)
|
